2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Kerato Conjunctivitis Sicca: new trials by email Literature Review of Kerato Conjunctivitis Sicca trials Research Report on Kerato Conjunctivitis Sicca
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye 5% Tavilermide ophthalmic solution, Vehicle ophthalmic solution - Dry Eye Syndromes, Dry Eye Disease | Phase 3 | Completed | Mimetogen Pharmaceuticals USA, Inc. | 642 | 2023-06-28 | 2024-06-10 |
| Safety and Efficacy of KPI-121 in Subjects With DED KPI-121 Ophthalmic Suspension, Vehicle - Kerato Conjunctivitis Sicca | Phase 3 | Completed | Kala Pharmaceuticals, Inc. | 901 | 2018-07-10 | 2021-04-02 |
Eye Diseases (2) · Lacrimal Apparatus Diseases (2)
Kala Pharmaceuticals, Inc. (1) · Mimetogen Pharmaceuticals USA, Inc. (1)
United States (2)